Used in pharmaceutical synthesis as an intermediate for kinase inhibitors, particularly in the development of targeted cancer therapies. The compound serves as a protected amine precursor, enabling selective coupling reactions in multi-step routes to bioactive molecules. Its pyridine and benzyl motifs support binding to enzyme active sites, making it valuable in optimizing potency and selectivity during drug design. Commonly employed in medicinal chemistry for constructing small-molecule inhibitors with improved metabolic stability.